Physiologically based modeling of the accumulation in plasma and tissue lipids of a mixture of PCB congeners in female sprague-dawley rats

Journal of Toxicology and Environmental Health - Part A

Volumn 68, Issue 16, 2005, Pages 1393-1412

  Emond, Claude ^a   Charbonneau, Michel ^b   Krishnan, Kannan ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCHLORINATED BIPHENYL; LIPID;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; BIOLOGICAL MONITORING; BLOOD FLOW VELOCITY; DRUG ACCUMULATION; DRUG RETENTION; DRUG SOLUBILITY; DRUG TISSUE LEVEL; FEMALE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER METABOLISM; METABOLIC RATE; NONHUMAN; PRIORITY JOURNAL; RAT; SIMULATION; TISSUE DISTRIBUTION; ANIMAL; BLOOD; CHEMISTRY; COMPUTER SIMULATION; LIVER; METABOLISM; POLLUTANT; SPRAGUE DAWLEY RAT;

ANIMALIA;

ADIPOSE TISSUE; ANIMALS; COMPUTER SIMULATION; ENVIRONMENTAL POLLUTANTS; FEMALE; LIPID METABOLISM; LIPIDS; LIVER; MODELS, BIOLOGICAL; POLYCHLORINATED BIPHENYLS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 23844534834     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390590956551     Document Type: Article

References (47)

1. Anderson, M. W., Eling, T. E., Lutz, R. J., Dedrick, R. L., and Matthews, H. B. 1977. The construction of a pharmacokinetic model for the disposition of polychlorinated biphenyls in the rat. Clin Pharmacol Ther. 22:765-773.
2. Aronson, K. J., Miller, A. B., Woolcott, C. G., Sterns, E. E., McCready, D. R., Fish, E. B., Hiraki, G. Y., Lickley, L. A., Holloway, C., Ross, T., Hanna, W. M., SenGupta, S. K., and Weber, J.-P. 2000. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol. Biomarkers Prevent. 9:55-63.
3. Birnbaum, L. S. 1985. The role of structure in the disposition of halogenated aromatic xenobiotics. Environ. Health Perspect. 61:11-20.
4. Brinkman, U. A., and de Kok, A. 1980. Production, properties and usage. In Halogenated biphenyls, terphenyls, naphathalenes, dibenzodioxins and related products, ed. R. D. Kimbrough, pp. 1-40. New York: Elsevier.
5. Carrier, G. 1991. Réponse de l'organisme humain aux BPC, dioxines et furannes et analyse des risques toxiques. Québec, : Le passeur.
6. Chevrier, J., Dewailly, E., Ayotte, P., Mauriege, P., Despres, J. P., and Tremblay, A. 2000. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. Int. J. Obesity Related Metab Disorders 24:1272-1278.
7. Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D., and Anton-Culver, H. 1993. Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environ. Health Perspect. 101:372-377.
8. De Jongh, J., Nieboer, R., Schroders, I., Seinen, W., and Van den Berg, M. 1993. Toxicokinetic mixture interactions between chlorinated aromatic hydrocarbons in the liver of the C57BL/6J mouse: 2. Polychlorinated dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and biphenyls (PCBs). Arch.Toxicol. 67:598-604.
9. Dewailly, E., Ayotte, P., Bruneau, S., Laliberte, C., Muir, D. G., and Norstrom, R. J. 1993. Inuit exposure to organochlorines through the aquatic food chain in Arctic Quebec. Environ. Health Perspect. 101 (7): 618-620.
10. Dewailly, E., Laliberté, C., Lebel, G., Ayotte, P., Weber, J.-P., and Holub, B. 1998. Évaluation de l'exposition prénatale aux organochlorés, aux métaux lourds et aux acides gras oméga-3 des populations de la Moyenne et Basse-Côte-nord du Saint-Laurent Rapport Saint-Laurent Vison 2000. Unité de recherche en santé publique. Université de Laval.
11. Dewailly, E., Mulvad, G., Pedersen, H. S., Ayotte, P., Demers, A., Weber, J.-P., and Hansen, J. C. 1999. Concentration of organochlorines in human brain, liver, and adipose tissue autopsy samples from Greenland. Environ. Health Perspect. 107:823-828.
12. Dragnev, K. H., Nims, R. W., Fox, S. D., Lindahl, R., and Lubet, R. A. 1995. Relative potencies of induction of hepatic drug-metabolizing enzyme genes by individual PCB congeners. Toxicol. Appl. Pharmacol. 132:334-342.
13. Fadhel, Z., Lu, Z., Robertson, L. W., and Glauert, H. P. 2002. Effect of 3,3',4,4'-tetrachlorobiphenyl and 2,2',4,4',5,5'- hexachlorobiphenyl on the induction of hepatic lipid peroxidation and cytochrome P-450 associated enzyme activities in rats. Toxicology 175:15-25.
14. Gerstenberger, S. L., Dellinger, J. A., and Hansen, L. G. 2000. Concentrations and frequencies of polychlorinated biphenyl congeners in a Native American population that consumes Great Lakes fish. J. Toxicol. Clinm. Toxicol. 38:729-746.
15. Goldstein, J. A., Hickman, P., Burse, V. W., and Bergman, H. 1975. A comparative study of two polychlorinated biphenyl mixtures (Aroclors 1242 and 1016) containing 42% chlorine on induction of hepatic porphyria and drug metabolizing enzymes. Toxicol. Appl. Pharmacol. 32:461-473.
16. Guiney, P. D., Yang, K. H., Seymour, J. L., and Peterson, R. E. 1978. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the distribution and biliary excretion of polychlorinated biphenyls in rats. Toxicol. Appl. Pharmacol. 45:403-414.
17. Haddad, S., Beliveau, M., Tardif, R., and Krishnan, K. 2001. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures. Toxicol. Sci. 63:125-131.
18. Howard, P. H., and Meylan, W. M. 1997. Handbook of physical properties of organic chemicals. New York: CRC Lewis .
19. Kedderis, L. B., Mills, J. J., Andersen, M. E., and Birnbaum, L. S. 1993. A physiological based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p- dioxin (TBDD) in the rat: Tissue distribution and CYP1 A induction. Toxicol. App. Pharmacol. 121:87-98.
20. Kosatsky, T., Shatenstein, B., Przybysz, R., and Nadon, S. 1998. Risk and benefits related to consumption of St. Lawrence river sport fish - Final report Rapport Saint-Laurent Vision 2000. http://www.siv2000.qc.ca.
21. Kostyniak, P. J., Stinson, C., Greizerstein, H. B., Vena, J., Buck, G., and Mendola, P. 1999. Relation of Lake Ontario fish consumption, lifetime lactation, and parity to breast milk polychlorobiphenyl and pesticide concentrations. Environ. Res. 80:S166-S174.
22. Kreuzer, P. E., Csanady, G. A., Baur, C., Kessler, W., Papke, O., Greim, H., and Filser, J. G. 1997. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Arch. Toxicol. 71:383-400.
23. Krishnan, K., and Andersen, M. E. 2001. Physiologically based pharmacokinetic modeling in toxicology. In Principles and methods of toxicology, ed. A. W. Hayes, pp. 1931-1241. New York: Raven Press.
24. Lebel, G., Dodin, S., Ayotte, P., Marcoux, S., Ferron, L. A., and Dewailly, E. 1998. Organochlorine exposure and the risk of endometriosis. Fertil. Steril. 69:221-228.
25. Lee, S. K., Ou, Y. C., and Yang, R. S. 2002. Comparison of pharmacokinetic interactions and physiologically based pharmacokinetic modeling of PCB 153 and PCB 126 in nonpregnant mice, lactating mice, and suckling pups. Toxicol. Sci. 65:26-34.
26. Leung, H. W., Paustenbach, D. J., Murray, F. J., and Andersen, M. E. 1990. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Toxicol. Appl. Pharmacol. 103:399-410.
27. Lindstrom, F. T., Gillett, J. W., and Rodecap, S. E. 1976. Distribution of HEOD (Dieldrin) in mammals: III Transport-transfer. Arch. Environ. Contam. Toxicol. 4:257-288.
28. Longnecker, M. P., Gladen, B. C., Patterson, D. G., Jr., and Rogan, W. J. 2000. Polychlorinated biphenyl (PCB) exposure in relation to thyroid hormone levels in neonates. Epidemiology 11:249-254.
29. Lutz, R. J., Dedrick, R. L., Matthews, H. B., Eling, T. E., and Anderson, M. W. 1977. A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat. Drug Metab. Dispos. 5:386-396.
30. Lutz, R. J., Dedrick, R. L., Tuey, D., Sipes, I. G., Anderson, M. W., and Matthews, H. B. 1984. Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model. Drug Metab. Dispos. 12:527-535.
31. McFarland, V. A., and Clarke, J. U. 1989. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: Considerations for a congener-specific analysis. Environ. Health Perspect. 81:225-239.
32. Muckle, G., Ayotte, P., Dewailly, E. E., Jacobson, S. W., and Jacobson, J. L. 2001. Prenatal exposure of the northern Quebec Inuit infants to environmental contaminants. Environ.Health Perspect. 109:1291-1299.
33. Oberg, M., Sjodin, A., Casabona, H., Nordgren, I., Klasson-Wehler, E., and Hakansson, H. 2002. Tissue distribution and half-lives of individual polychlorinated biphenyls and serum levels of 4-hydroxy-2,3,3',4',5- pentachlorobiphenyl in the rat. Toxicol. Sci. 70 (2): 171-182.
34. Osius, N., Karmaus, W., Kruse, H., and Witten, J. 1999. Exposure to polychlorinated biphenyls and levels of thyroid hormones in children. Environ. Health Perspect. 107:843-849.
35. Parham, F. M., and Portier, C. J. 1998. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls. II. Rates of metabolism. Toxicol. Appl. Pharmacol. 151:110-116.
36. Patterson, D. G. Jr, Isaacs, S. G., Alexander, L. R., Turner, W. E., Hampton, L., Bernert, J. T., and Needham, L. L. 1991. Method 6: Determination of specific polychlorinated dibenzo-p-dioxins and dibenzofurans in blood and adipose tissue by isotope dilution - High-resolution mass spectrometry. IARC Sci. Publ. 108.
37. Platonow, N. S., Liptrap, R. M., and Geissinger, H. D. 1972. The distribution and excretion of polychlorinated biphenyls (Aroclor 1254) and their effect on urinary gonadal steroid levels in the boar. Bull. Environ. Contam.Toxicol. 7:358-365.
38. Poulin, P., and Krishnan, K. 1996. Molecular structure-based prediction of the partition coefficients of organic chemicals for physiological pharmacokinetic models. Toxicol. Methods 6:117-137.
39. Ramsey, J. C., and Andersen, M. E. 1984. A physiologically based description of the inhalation pharmacokinetics of styrene in rat and human. Toxicol. Appl. Pharmacol. 73:159-175.
40. Romieu, I., Hernandez-Avila, M., Lazcano-Ponce, E., Weber, J. P., and Dewailly, E. 2000. Breast cancer, lactation history, and serum organochlorines. Am. J. Epidemiol. 152:363-370.
41. Rozman, K. K., Stahl, B. U., Kerecsen, L., and Kettrup, A. 1995. Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. IV. Determination of liver concentrations. Arch.Toxicol. 69:547-551.
42. Schmitz, H.-J., Hagenmaier, A., Bock, K. W., and Schrenk, D. 1995. Potency of mixtures of polychlorinated biphenyls as inducers of dioxin receptor-regulated CYP1 A activity in rat hepatocytes and H4IIE cells. Toxicology 99:47-54.
43. Toyoshiba, H., Walker, N. J., Bailer, A. J., and Portier, C. J. 2004. Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1 A1 and CYP1 A2 enzyme activity by dioxin-like compounds. Toxicol. Appl. Pharmacol. 194:156-168.
44. Tuey, D. B., and Matthews, H. B. 1977. Pharmacokinetics of 3,3',5,5'-tetrachlorobiphenyl in the male rat. Drug Metab. Dispos. 5:444-450.
45. Tuey, D. B., and Matthews, H. B. 1980. Distribution and excretion of 2,2',4,4',5,5'-hexabromobiphenyl in rats and man: Pharmacokinetic model predictions. Toxicol. Appl. Pharmacol. 53:420-431.
46. van der Molen, G. W., Kooijman, S. A., and Slob, W. 1996. A generic toxicokinetic model for persistent lipophilic compounds in humans: An application to TCDD. Fundam. Appl. Toxicol. 31:83-94.
47. Wang, X., Santostefano, M. J., Evans, M. V., Richardson, V. M., Diliberto, J. J., and Birnbaum, L. S. 1997. Determination of parameters responsible for pharmacokinetic behaviour of TCDD in female Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 147:151-168.